<VariationArchive VariationID="2692351" VariationName="NM_001145128.3(AK9):c.4872_4875dup (p.Cys1626fs)" VariationType="Duplication" Accession="VCV002692351" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2024-02-14" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2853352" VariationID="2692351">
      <GeneList>
        <Gene Symbol="AK9" FullName="adenylate kinase 9" GeneID="221264" HGNC_ID="HGNC:33814" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="109492855" stop="109691202" display_start="109492855" display_stop="109691202" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="109814058" stop="110012414" display_start="109814058" display_stop="110012414" Strand="-" />
          </Location>
          <OMIM>615358</OMIM>
        </Gene>
        <Gene Symbol="ZBTB24-DT" FullName="ZBTB24 divergent transcript" GeneID="105377935" HGNC_ID="HGNC:55872" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="109483644" stop="109506852" display_start="109483644" display_stop="109506852" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001145128.3(AK9):c.4872_4875dup (p.Cys1626fs)</Name>
      <CanonicalSPDI>NC_000006.12:109499214:TAACT:TAACTAACT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="109499214" stop="109499215" display_start="109499214" display_stop="109499215" variantLength="4" positionVCF="109499214" referenceAlleleVCF="A" alternateAlleleVCF="ATAAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="109820417" stop="109820418" display_start="109820417" display_stop="109820418" variantLength="4" positionVCF="109820417" referenceAlleleVCF="A" alternateAlleleVCF="ATAAC" />
      </Location>
      <ProteinChange>C1626fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.109820419_109820422dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.109820419_109820422dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.109499216_109499219dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.109499216_109499219dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145128.3" sequenceAccession="NM_001145128" sequenceVersion="3" change="c.4872_4875dup" MANESelect="true">
            <Expression>NM_001145128.3:c.4872_4875dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138600.2" sequenceAccession="NP_001138600" sequenceVersion="2" change="p.Cys1626fs">
            <Expression>NP_001138600.2:p.Cys1626fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="615358.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001145128.3(AK9):c.4872_4875dup (p.Cys1626fs) AND Spermatogenic failure 89" Accession="RCV003494548" Version="2">
        <ClassifiedConditionList TraitSetID="93444">
          <ClassifiedCondition DB="MedGen" ID="C5882752">Spermatogenic failure 89</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-02-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">37713809</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="93444" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="72552" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spermatogenic failure 89</ElementValue>
                <XRef ID="MONDO:0958206" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SPGF89</ElementValue>
                <XRef Type="MIM" ID="620705" DB="OMIM" />
              </Symbol>
              <XRef ID="C5882752" DB="MedGen" />
              <XRef ID="MONDO:0958206" DB="MONDO" />
              <XRef Type="MIM" ID="620705" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7928614" SubmissionDate="2024-02-05" DateLastUpdated="2024-03-10" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="615358.0001_SPERMATOGENIC FAILURE 89" title="AK9, 4-BP DUP, 4872GTTA_SPERMATOGENIC FAILURE 89" />
        <ClinVarAccession Accession="SCV004244329" DateUpdated="2024-03-10" DateCreated="2024-02-14" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 31-year-old Chinese man (family F013) with infertility due to asthenozoospermia (SPGF89; 620705), Sha et al. (2023) identified homozygosity for a 4-bp duplication (c.4872_4875dupGTTA, NM_152327) in the AK9 gene, causing a frameshift predicted to result in a premature termination codon (Cys1626ValfsTer16). His consanguineous parents were heterozygous for the mutation, which was not found in the ExAC or 1000 Genomes Project databases, but was present at very low minor allele frequency in gnomAD, including in the East Asian population. Analysis of spermatozoa from the proband showed significantly reduced glycolysis-related metabolites compared to control sperm, and 18-O-labeled ATP was also significantly reduced, indicating insufficient AK-catalyzed phosphotransfer in patient sperm.</Attribute>
              <Citation>
                <ID Source="PubMed">37713809</ID>
              </Citation>
              <XRef DB="OMIM" ID="620705" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AK9" />
          </GeneList>
          <Name>AK9, 4-BP DUP, 4872GTTA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, 4872GTTA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="615358.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPERMATOGENIC FAILURE 89</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7928614" TraitType="Disease" MappingType="Name" MappingValue="SPERMATOGENIC FAILURE 89" MappingRef="Preferred">
        <MedGen CUI="C5882752" Name="Spermatogenic failure 89" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

